IMBRUVICA® (ibrutinib)

Bruton's Tyrosine Kinase (BTK) Inhibitor

Potential of IMBRUVICA®

We are committed to fully exploring the potential of IMBRUVICA's unique mechanism of action against tumor cells and in the immune system in multiple diseases over the next 5+ years, both as a single agent and in combination with a wide variety of other therapies.